XYZ vs. MRNA

Last updated Jun 5, 2026

XYZ (Block, Inc) and MRNA (Moderna, Inc.) are both stocks. XYZ operates in Software - Infrastructure (Technology), while MRNA operates in Biotechnology (Healthcare). Over the past 5 years, XYZ returned -19.80%/yr vs -24.19%/yr for MRNA. At a 0.30 correlation, their price movements are largely independent.

Performance

XYZ vs. MRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Block, Inc (XYZ) and Moderna, Inc. (MRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XYZ achieves a 8.91% return, which is significantly lower than MRNA's 74.94% return.

XYZ

• 1D: 1.56%
• 1M: -0.51%
• YTD: 8.91%
• 6M: 13.99%
• 1Y: 11.01%
• 3Y*: 3.72%
• 5Y*: -19.80%
• 10Y*: 22.25%

MRNA

• 1D: 5.16%
• 1M: 10.45%
• YTD: 74.94%
• 6M: 102.39%
• 1Y: 89.18%
• 3Y*: -26.31%
• 5Y*: -24.19%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XYZ vs. MRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
XYZ Block, Inc	8.91%	-23.41%	9.88%	23.09%	-61.09%	-25.79%	247.89%	11.54%	-7.72%
MRNA Moderna, Inc.	74.94%	-29.08%	-58.19%	-44.63%	-29.28%	143.11%	434.10%	28.09%	-17.90%

Correlation

The correlation between XYZ and MRNA is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.33
Correlation (3Y) Calculated over the trailing 3-year period	0.33
Correlation (5Y) Calculated over the trailing 5-year period	0.38
Correlation (All Time) Calculated using the full available price history since Dec 10, 2018	0.30

Fundamentals

Market Cap XYZ : $42.36B MRNA : $20.38B
EPS XYZ : $1.31 MRNA : -$8.16
PS Ratio XYZ : 1.78 MRNA : 9.07
PB Ratio XYZ : 1.95 MRNA : 2.75
Total Revenue (TTM) XYZ : $24.48B MRNA : $2.23B
Gross Profit (TTM) XYZ : $11.01B MRNA : -$309.00M
EBITDA (TTM) XYZ : $2.42B MRNA : -$3.02B

Return for Risk

XYZ vs. MRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XYZ

XYZ Risk / Return Rank: 48
XYZ Sharpe Ratio Rank: 50
XYZ Sortino Ratio Rank: 46
XYZ Omega Ratio Rank: 46
XYZ Calmar Ratio Rank: 49
XYZ Martin Ratio Rank: 49

MRNA

MRNA Risk / Return Rank: 78
MRNA Sharpe Ratio Rank: 80
MRNA Sortino Ratio Rank: 79
MRNA Omega Ratio Rank: 74
MRNA Calmar Ratio Rank: 79
MRNA Martin Ratio Rank: 75

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XYZ vs. MRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Block, Inc (XYZ) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XYZ	MRNA	Difference
Sharpe ratio: Return per unit of total volatility	0.24	1.40	-1.16
Sortino ratio: Return per unit of downside risk	0.66	2.25	-1.59
Omega ratio: Gain probability vs. loss probability	1.08	1.25	-0.17
Calmar ratio: Return relative to maximum drawdown	0.28	2.53	-2.25
Martin ratio: Return relative to average drawdown	0.65	5.00	-4.35
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XYZ vs. MRNA - Sharpe Ratio Comparison

The current XYZ Sharpe Ratio is 0.24, which is lower than the MRNA Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of XYZ and MRNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XYZ	MRNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.24	1.40	-1.16
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.33	-0.37	+0.03
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.39	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.31	0.20	+0.10

Drawdowns

XYZ vs. MRNA - Drawdown Comparison

The maximum XYZ drawdown since its inception was -86.08%, smaller than the maximum MRNA drawdown of -95.38%. Use the drawdown chart below to compare losses from any high point for XYZ and MRNA.

Drawdown Indicators

	XYZ	MRNA	Difference
Max Drawdown Largest peak-to-trough decline	-86.08%	-95.38%	+9.30%
Max Drawdown (1Y) Largest decline over 1 year	-39.48%	-35.51%	-3.97%
Max Drawdown (3Y) Largest decline over 3 years	-52.96%	-86.58%	+33.62%
Max Drawdown (5Y) Largest decline over 5 years	-86.08%	-95.38%	+9.30%
Max Drawdown (10Y) Largest decline over 10 years	-86.08%	—	—
Current Drawdown Current decline from peak	-74.84%	-89.35%	+14.51%
Average Drawdown Average peak-to-trough decline	-40.99%	-56.66%	+15.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	16.99%	17.90%	-0.91%

Volatility

XYZ vs. MRNA - Volatility Comparison

The current volatility for Block, Inc (XYZ) is 13.37%, while Moderna, Inc. (MRNA) has a volatility of 18.65%. This indicates that XYZ experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XYZ	MRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.37%	18.65%	-5.28%
Volatility (6M) Calculated over the trailing 6-month period	35.04%	48.15%	-13.11%
Volatility (1Y) Calculated over the trailing 1-year period	46.53%	64.07%	-17.54%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.97%	66.39%	-6.42%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	56.67%	71.92%	-15.25%

Dividends

XYZ vs. MRNA - Dividend Comparison

Neither XYZ nor MRNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both XYZ and MRNA in my portfolio?

XYZ and MRNA have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, XYZ or MRNA?

MRNA has higher volatility (18.65%) compared to XYZ (13.37%). In terms of maximum drawdown, XYZ dropped -86.08% vs MRNA's -95.38%.

Which has better risk-adjusted returns?

MRNA currently has the higher Sharpe Ratio (1.40 vs 0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.